Swiss Medical Equipment Stock News

Ascom Holding AG's ( VTX:ASCN ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a strong buy right now...

Key Insights Burkhalter Holding's significant retail investors ownership suggests that the key decisions are influenced...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Ypsomed Holding has seen its consensus analyst price target dip from CHF463.26 to CHF449.37, reflecting mixed analyst sentiment. Recent commentary highlights both bullish confidence in Ypsomed's leadership in the injectable market, as well as caution from others who question the sustainability of its growth following a company transformation. Stay tuned to discover how you can keep up with shifts in the evolving narrative for Ypsomed Holding stock. What Wall Street Has Been Saying Analyst...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Sika fair value estimate is CHF284 Current share price of...

What financial metrics can indicate to us that a company is maturing or even in decline? Businesses in decline often...

If you are standing at the crossroads of whether to buy, sell, or hold Julius Bär Gruppe, you are not alone. Investors have watched the stock make some strong moves in recent years, and there is a real question about whether the current price offers genuine value or a reason for caution. The stock’s journey has been anything but dull: while the past week and month have brought noticeable dips (down 5.7% and 8.7%, respectively), anyone who zooms out will see that the last twelve months...

VAT Group's (VTX:VACN) stock is up by a considerable 26% over the past month. Given the company's impressive...

With its stock down 3.9% over the past three months, it is easy to disregard INFICON Holding (VTX:IFCN). However, a...

While Rieter Holding AG ( VTX:RIEN ) might not have the largest market cap around , it received a lot of attention from...

To the annoyance of some shareholders, Rieter Holding AG ( VTX:RIEN ) shares are down a considerable 25% in the last...

The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...

As European markets navigate a landscape of mixed economic signals and monetary policy decisions, the pan-European STOXX Europe 600 Index recently ended the week slightly lower. In this environment, dividend stocks may offer investors a potential source of steady income, especially as central banks maintain cautious stances on interest rates.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Galenica AG's ( VTX:GALE ) price-to-earnings (or "P/E") ratio of 21.9x might make it look like a sell right now...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Georg Fischer AG ( VTX:GF ), is not the largest company out there, but it maintained its current share price over the...

Despite posting some strong earnings, the market for Temenos AG's ( VTX:TEMN ) stock hasn't moved much. Our analysis...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Medacta Group SA recently reported strong half-year earnings, with sales reaching €344.14 million and net income rising to €60.04 million, while confirming 2025 guidance targeting 16% to 18% revenue growth in constant currency. Alongside these financial results, the company continued to expand its Personalized Sports Medicine Portfolio, launching the QuickStitch device at a major industry congress, highlighting ongoing investment in innovation and physician education. We'll examine how...

A big shake-up is underway at Lonza Group (SWX:LONN). The company just announced two senior leadership appointments that could set the stage for its next chapter. Jason Berndt is stepping in as Head of Group Operations and Executive Vice President, while Maria Soler Nunez will become Chief Quality Officer. Both bring a wealth of pharmaceutical and operations expertise from global industry heavyweights. This signals that Lonza is doubling down on strengthening its execution and quality...

Key Insights Insiders appear to have a vested interest in Ypsomed Holding's growth, as seen by their sizeable ownership...